Thalassemia Intermedia

• CLINICAL_TRIALS research · 2026-02-11
  Clinical Trial Update: Growth Evaluation, Health Promotion, and Clinical Management in Children and Adolescents With Thalassemia [NA]

  This trial investigates growth evaluation, health promotion, and clinical management in children and adolescents with thalassemia intermedia…

• CLINICAL_TRIALS trial_result · 2025-04-02
  Clinical Trial Update: EDIT-301 for Autologous Hematopoietic Stem Cell Transplant (HSCT) in Participants With Transfusion-Dependent Beta Thalassemia (TDT) [Phase 1, Phase 2]

  Editas Medicine reports an update for EDIT-301, an autologous hematopoietic stem cell gene-editing therapy, currently in Phase 1/Phase 2 for…

• CLINICAL_TRIALS trial_result · 2020-02-05
  Clinical Trial Update: Efficacy and Safety of Neridronate (Nerixia®)to Treat Osteoporosis in Patients With TM and TI [Phase 2]

  Phase 2 trial update on neridronate (Nerixia) for osteoporosis in patients with thalassemia major/intermedia showing efficacy and safety res…

• CLINICAL_TRIALS trial_result · 2017-02-10
  Clinical Trial Update: Traditional Chinese Medicine in the Supportive Management of Anaemic and Cytopenic (Leukopenia, Thrombocytopenia) Haematological Disorders [Phase 1, Phase 2]

  A completed Phase 1/2 study from Singapore General Hospital evaluated a Traditional Chinese Medicine formulation for supportive management o…

• CLINICAL_TRIALS trial_result · 2014-04-08
  Clinical Trial Update: Evaluating the Safety and Effectiveness of Decitabine in People With Thalassemia Intermedia [Phase 2]

  Phase 2 study evaluating the safety and effectiveness of decitabine in people with thalassemia intermedia; the trial has completed and resul…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2012-06-20
  Clinical Trial Update: Therapeutic Effect and Safety of Combined Hydroxyurea With Recombinant Human Erythropoietin. [Phase 2, Phase 3]

  This document provides an update on a Phase 2/3 study evaluating the combination of hydroxyurea and recombinant human erythropoietin for Tha…

• CLINICAL_TRIALS trial_result · 2010-09-14
  Clinical Trial Update: GDF 15 in Sickle Cell Disease and Hereditary Spherocytosis

  Clinical trial update concerning growth differentiation factor 15 (GDF15) in sickle cell disease and hereditary spherocytosis, with listed c…